302 related articles for article (PubMed ID: 11888329)
21. Blood-brain barrier efflux transport.
Golden PL; Pollack GM
J Pharm Sci; 2003 Sep; 92(9):1739-53. PubMed ID: 12949994
[TBL] [Abstract][Full Text] [Related]
22. Role of CNS transporters in the pharmacotherapy of HIV-1 associated neurological disorders.
Ashraf T; Robillard K; Chan GN; Bendayan R
Curr Pharm Des; 2014; 20(10):1543-63. PubMed ID: 23789949
[TBL] [Abstract][Full Text] [Related]
23. Drug delivery across the blood-brain barrier: why is it difficult? how to measure and improve it?
Su Y; Sinko PJ
Expert Opin Drug Deliv; 2006 May; 3(3):419-35. PubMed ID: 16640501
[TBL] [Abstract][Full Text] [Related]
24. Regulation of ABC transporters at the blood-brain barrier: new targets for CNS therapy.
Hartz AM; Bauer B
Mol Interv; 2010 Oct; 10(5):293-304. PubMed ID: 21045243
[TBL] [Abstract][Full Text] [Related]
25. Pregnane X receptor upregulates ABC-transporter Abcg2 and Abcb1 at the blood-brain barrier.
Lemmen J; Tozakidis IE; Galla HJ
Brain Res; 2013 Jan; 1491():1-13. PubMed ID: 23123212
[TBL] [Abstract][Full Text] [Related]
26. Why clinical modulation of efflux transport at the human blood-brain barrier is unlikely: the ITC evidence-based position.
Kalvass JC; Polli JW; Bourdet DL; Feng B; Huang SM; Liu X; Smith QR; Zhang LK; Zamek-Gliszczynski MJ;
Clin Pharmacol Ther; 2013 Jul; 94(1):80-94. PubMed ID: 23588303
[TBL] [Abstract][Full Text] [Related]
27. Nanoparticle transport across the blood brain barrier.
Grabrucker AM; Ruozi B; Belletti D; Pederzoli F; Forni F; Vandelli MA; Tosi G
Tissue Barriers; 2016; 4(1):e1153568. PubMed ID: 27141426
[TBL] [Abstract][Full Text] [Related]
28. Transporter hypothesis of drug-resistant epilepsy: challenges for pharmacogenetic approaches.
Potschka H
Pharmacogenomics; 2010 Oct; 11(10):1427-38. PubMed ID: 21047204
[TBL] [Abstract][Full Text] [Related]
29. Strategy for effective brain drug delivery.
Alam MI; Beg S; Samad A; Baboota S; Kohli K; Ali J; Ahuja A; Akbar M
Eur J Pharm Sci; 2010 Aug; 40(5):385-403. PubMed ID: 20497904
[TBL] [Abstract][Full Text] [Related]
30. Estimation of the unbound brain concentration of P-glycoprotein substrates or nonsubstrates by a serial cerebrospinal fluid sampling technique in rats.
Mariappan TT; Kurawattimath V; Gautam SS; Kulkarni CP; Kallem R; Taskar KS; Marathe PH; Mandlekar S
Mol Pharm; 2014 Feb; 11(2):477-85. PubMed ID: 24380373
[TBL] [Abstract][Full Text] [Related]
31. Multidrug resistance protein MRP2 contributes to blood-brain barrier function and restricts antiepileptic drug activity.
Potschka H; Fedrowitz M; Löscher W
J Pharmacol Exp Ther; 2003 Jul; 306(1):124-31. PubMed ID: 12663688
[TBL] [Abstract][Full Text] [Related]
32. Involvement of organic anion transporters in the efflux of uremic toxins across the blood-brain barrier.
Deguchi T; Isozaki K; Yousuke K; Terasaki T; Otagiri M
J Neurochem; 2006 Feb; 96(4):1051-9. PubMed ID: 16445853
[TBL] [Abstract][Full Text] [Related]
33. Strategies for transporting nanoparticles across the blood-brain barrier.
Zhang TT; Li W; Meng G; Wang P; Liao W
Biomater Sci; 2016 Feb; 4(2):219-29. PubMed ID: 26646694
[TBL] [Abstract][Full Text] [Related]
34. Blood-brain barrier endogenous transporters as therapeutic targets: a new model for small molecule CNS drug discovery.
Pardridge WM
Expert Opin Ther Targets; 2015; 19(8):1059-72. PubMed ID: 25936389
[TBL] [Abstract][Full Text] [Related]
35. Differential receptor-mediated drug targeting to the diseased brain.
Rip J; Schenk GJ; de Boer AG
Expert Opin Drug Deliv; 2009 Mar; 6(3):227-37. PubMed ID: 19327042
[TBL] [Abstract][Full Text] [Related]
36. Tools in the Design of Therapeutic Drugs for CNS Disorders: An up-to-date Review.
Sahu JK; Mishra AK
Curr Mol Pharmacol; 2018; 11(4):270-278. PubMed ID: 30129422
[TBL] [Abstract][Full Text] [Related]
37. The role of size and charge for blood-brain barrier permeation of drugs and fatty acids.
Seelig A
J Mol Neurosci; 2007 Sep; 33(1):32-41. PubMed ID: 17901543
[TBL] [Abstract][Full Text] [Related]
38. Prodrugs and endogenous transporters: are they suitable tools for drug targeting into the central nervous system?
Pavan B; Dalpiaz A
Curr Pharm Des; 2011; 17(32):3560-76. PubMed ID: 22074427
[TBL] [Abstract][Full Text] [Related]
39. CNS transporters and drug delivery in epilepsy.
Potschka H; Luna-Munguia H
Curr Pharm Des; 2014; 20(10):1534-42. PubMed ID: 23789955
[TBL] [Abstract][Full Text] [Related]
40. The blood-brain barrier efflux transporters as a detoxifying system for the brain.
Terasaki T; Hosoya K
Adv Drug Deliv Rev; 1999 Apr; 36(2-3):195-209. PubMed ID: 10837716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
